Pharmaceutical Industry in
Glattbrugg

Vifor Pharma Management AG

Since 2008 · 101–500 empl.·4.4(8)

The core activity of CSL Vifor is the development, manufacture and marketing of pharmaceutical products, particularly in the areas of iron deficiency, nephrology and cardiorenal therapies. The company focuses on the development of innovative therapies for rare diseases and unmet medical needs, positioning itself as a global partner for strategic partnerships and in-licensing.

Virbac (Switzerland) AG

Since 1988 · 101–500 empl.

The core activity of Virbac is the development and distribution of products for animal health, particularly for the prevention and treatment of diseases in animals, as well as promoting animal welfare and sustainable animal husbandry.

GE Healthcare AG

Since 2000 · 101–500 empl.

GE Healthcare AG is a medical technology company that provides imaging systems and modalities including ultrasound, CT, MRI, mammography and molecular imaging. It also supplies contrast media and nuclear imaging agents, patient monitoring and perioperative solutions, healthcare IT and digital services, alongside lifecycle services such as maintenance, predictive services, cybersecurity and financing.

Otsuka Pharmaceutical (Switzerland) GmbH

Since 2013 · 11–20 empl.

The core activity of Otsuka Pharmaceutical Europe Ltd. is the development, manufacture and marketing of pharmaceutical products and nutritional supplements (Nutraceuticals) to improve the health and well-being of people worldwide.

Dr. Falk Pharma AG

Since 2020 · 11–20 empl.

Dr. Falk Pharma AG is a company in digestive and metabolic medicine that develops and distributes pharmaceuticals for gastroenterology and hepatology. Its activities include marketing prescription medicines (e.g. Salofalk, Budenofalk, Ursofalk, Jorveza, Azafalk), supporting medical projects, and providing educational and patient information resources.

Prexton Therapeutics AG

Since 2012 · 1–10 empl.